Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-4-27
pubmed:abstractText
The inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against a collection of 479 methicillin-resistant Staphylococcus aureus isolates were assessed. The isolates were collected from U.S. and European hospitals from 1985 to 2007 and were primarily from blood and abscess cultures. The MICs and minimum bactericidal concentrations (MBCs) of the three agents were determined, and the MBC/MIC ratios were calculated to determine the presence or absence of tolerance. Tolerance was defined as an MBC/MIC ratio of > or = 32 or an MBC/MIC ratio of > or = 16 when the MBC was greater than or equal to the breakpoint for resistance. Tolerance to vancomycin and teicoplanin was observed in 6.1% and 18.8% of the strains, respectively. Tolerance to daptomycin was not observed.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-10325341, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-10459820, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-11864946, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-12775678, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-1423219, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-14999632, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-15184410, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-15378442, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-15561842, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-16323115, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-16534785, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-16801409, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-17040922, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-17043121, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-17116684, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-17452488, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-17531446, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-18039923, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-2393284, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-3541781, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-475520, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-8203842, http://linkedlifedata.com/resource/pubmed/commentcorrection/19223623-9738836
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1098-6596
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
53
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1735-8
pubmed:dateRevised
2010-9-23
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Inhibitory and bactericidal activities of daptomycin, vancomycin, and teicoplanin against methicillin-resistant Staphylococcus aureus isolates collected from 1985 to 2007.
pubmed:affiliation
Clinical Microbiology Institute, 9725 SW Commerce Circle, Suite A-1, Wilsonville, OR 97070, USA. mtrac@clinmicroinst.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't